Use of opioids, SSRIs linked to increased fracture risk in RANovember 7, 2017PainRheumatoid ArthritisOsteoporosisOrthopedicsPain
Romosozumab reduces fracture risk out to 36 months, with no signs of cardiovascular problemsSeptember 26, 2017Osteoporosis
Teriparatide reduces fractures over risedronate in all subgroups with osteoporosisSeptember 22, 2017Osteoporosis
Preferred osteoporosis treatment order with teriparatide, denosumab reaffirmedSeptember 21, 2017Osteoporosis
Worsening osteoporosis care for RA patients shows need for actionSeptember 11, 2017Rheumatoid ArthritisOsteoporosis
Study finds low risk for jaw osteonecrosis with denosumab for postmenopausal osteoporosisSeptember 9, 2017Osteoporosis
